In the news

December 4, 2012

The Barbara Ann Karmanos Cancer Center is the first hospital in the Midwest to offer the newest molecular breast imaging device - GE Healthcare's Discovery* NM750b. This molecular breast imaging (MBI) technology makes it possible to detect breast cancer in women considered to be at high-risk, especially those with dense breast tissue.
"Although molecular breast imaging does not take the place of mammography, it offers another option for patients who need additional imaging, such as magnetic resonance imaging (MRI)," said Dr. Sharon Helmer, clinical service chief, Imaging Department, and director, Breast Imaging, Karmanos Cancer Center; and clinical associate professor, Wayne State University School of Medicine. "The MBI system allows better detection of very small lesions in women with dense breast tissue. Not only will this help eliminate false positives, it may help to detect breast cancers earlier when the disease is highly survivable."

Share

Wayne State Office of Public Relations

The Wayne State University Office of Communications is the primary liaison between the university and the news media. We understand timeliness is critical in news reporting. Our goal is to deliver a rapid response to media inquiries and provide reporters with the most relevant experts and spokespeople.